[Clinical features of anti-HCV antibody positive hepatocellular carcinoma].
Hayashi
S
S
Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital.
Tanaka
S
S
Wakashima
M
M
Saeki
S
S
Tanaka
T
T
Shibayama
T
T
Otake
H
H
Hattori
N
N
D000956:Antigens, Viral; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000276:immunology* / Q000401:mortality; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology / Q000276:immunology* / Q000401:mortality; D011994:Recombinant Proteins / Q000276:immunology; D015996:Survival Rate; D065227:Transfusion Reaction; D017361:Viral Nonstructural Proteins; D014764:Viral Proteins / Q000276:immunology
D000956:Antigens, Viral; C064544:C100 protein, hepatitis C virus; D006508:Hepatitis Antibodies; D011994:Recombinant Proteins; D017361:Viral Nonstructural Proteins; D014764:Viral Proteins